Saudi Journal of Anaesthesia

CASE REPORT
Year
: 2017  |  Volume : 11  |  Issue : 2  |  Page : 232--235

A case report of suspected malignant hyperthermia where patient survived the episode


Asif Iqbal, Shoaib Badoo, Ruqsana Naqeeb 
 Department of Anaesthesiology and Critical Care, SMHS Hospital, GMC, Srinagar, Jammu and Kashmir, India

Correspondence Address:
Asif Iqbal
36, Ram Bagh Extension, Near Noorani Masjid, Srinagar - 190 015, Jammu and Kashmir
India

Malignant hyperthermia is rare inherited disorder in our part of the world; there are only few cases reported in literature in India who were suspected of having this condition. The overall incidence of malignant hyperthermia during general anesthesia is estimated to range from 1: 5000 to 1: 50,000–100,000 and mortality rate is estimated to be <5% in the presence of standard care. In India, there is no center where in vitro halothane caffeine contraction test is performed to confirm diagnosis in suspected cases. Second, dantrolene drug of choice for this condition is not freely available in market in India and is stored only in some hospitals in few major cities. Among the cases reported of suspected of malignant hyperthermia in India almost 50% have survived the condition despite nonavailability of dantrolene emphasizing role of early detection and aggressive management in these cases.


How to cite this article:
Iqbal A, Badoo S, Naqeeb R. A case report of suspected malignant hyperthermia where patient survived the episode.Saudi J Anaesth 2017;11:232-235


How to cite this URL:
Iqbal A, Badoo S, Naqeeb R. A case report of suspected malignant hyperthermia where patient survived the episode. Saudi J Anaesth [serial online] 2017 [cited 2022 Sep 25 ];11:232-235
Available from: https://www.saudija.org/article.asp?issn=1658-354X;year=2017;volume=11;issue=2;spage=232;epage=235;aulast=Iqbal;type=0